Regulus Therapeutics Inc. (RGLS) Ownership

$8.14

$0.26 (3.24%)
Last update: 11:30 AM EST
Day's range
$8.05
Day's range
$8.16

Regulus Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FEDERATED HERMES, INC. 05/08/2025 15.82 M $39.20 M   23.09% 23.91%
NEA MANAGEMENT COMPANY, LLC 05/14/2025 6.47 M $11.32 M   0.00% 9.77%
OCTAGON CAPITAL ADVISORS LP 05/16/2025 4.64 M $8.11 M   -4.37% 7.01%
BLACKROCK, INC. 05/02/2025 4.17 M $7.30 M   -1.56% 6.30%
VANGUARD GROUP INC 05/09/2025 3.95 M $6.92 M   -0.38% 5.97%
DEEP TRACK CAPITAL, LP 05/15/2025 3.26 M $5.71 M   0.00% 4.93%
VIVO CAPITAL, LLC 05/12/2025 2.70 M $4.72 M   -46.07% 4.07%
BAKER BROS. ADVISORS LP 05/15/2025 2.69 M $4.71 M   100.00% 4.07%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 1.97 M $3.44 M   119.89% 2.97%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 1.30 M $2.28 M   1.68% 1.97%
STATE STREET CORP 05/15/2025 1.04 M $1.81 M   -1.87% 1.57%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2025 937.50 K $1.64 M   -9.64% 1.42%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2025 847.18 K $1.48 M   -3.20% 1.28%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2025 452.85 K $792.48 K   100.00% 0.68%
NORTHERN TRUST CORP 05/13/2025 444.34 K $777.60 K   -2.82% 0.67%
VICTORY CAPITAL MANAGEMENT INC 05/02/2025 386.67 K $676.67 K   -0.83% 0.58%
WELLS FARGO & COMPANY/MN 05/13/2025 204.31 K $357.55 K   481.11% 0.31%
UBS GROUP AG 05/13/2025 184.89 K $323.56 K   105.10% 0.28%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 178.88 K $313.04 K   0.00% 0.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 150.81 K $263.92 K   316.75% 0.23%
BANK OF NEW YORK MELLON CORP 04/29/2025 149.36 K $261.37 K   0.00% 0.23%
CITADEL ADVISORS LLC 05/15/2025 148.28 K $259.49 K   -4.68% 0.22%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 147.90 K $258.83 K   26.30% 0.22%
GOLDMAN SACHS GROUP INC 05/16/2025 130.34 K $228.09 K   -38.63% 0.20%
TYCHE WEALTH PARTNERS LLC 04/23/2025 121.59 K $212.78 K   14.61% 0.18%
05/12/2025 85.60 K $149.80 K   100.00% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 84.20 K $147.35 K   514.60% 0.13%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 05/15/2025 80.00 K $140.00 K   14.29% 0.12%
MORGAN STANLEY 05/15/2025 77.62 K $135.84 K   -44.47% 0.12%
JPMORGAN CHASE & CO 05/12/2025 74.52 K $130.41 K   -60.87% 0.11%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 68.58 K $120.02 K   100.00% 0.10%
BARCLAYS PLC 05/15/2025 64.64 K $113.00 K   -32.84% 0.10%
RHUMBLINE ADVISERS 05/29/2025 57.74 K $101.05 K   -3.00% 0.09%
OPPENHEIMER & CO INC 04/23/2025 55.00 K $96.25 K   100.00% 0.08%
NEW YORK STATE COMMON RETIREMENT FUND 05/01/2025 49.40 K $86.00 K   0.00% 0.07%
CITIGROUP INC 05/12/2025 44.14 K $77.24 K   -11.97% 0.07%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 38.35 K $67.10 K   4.48% 0.06%
LPL FINANCIAL LLC 05/07/2025 37.98 K $66.47 K   -24.01% 0.06%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 32.41 K $56.72 K   13.80% 0.05%
COREBRIDGE FINANCIAL, INC. 05/14/2025 30.94 K $54.14 K   -1.46% 0.05%
BANK OF AMERICA CORP /DE/ 05/15/2025 29.94 K $52.39 K   -44.40% 0.05%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 29.60 K $52.00 K   0.00% 0.04%
INVESCO LTD. 05/12/2025 29.46 K $51.56 K   -2.61% 0.04%
ALLIANCEBERNSTEIN L.P. 05/15/2025 26.88 K $47.04 K   0.00% 0.04%
VOYA INVESTMENT MANAGEMENT LLC 06/18/2025 21.37 K $37.39 K   -7.39% 0.03%
SG AMERICAS SECURITIES, LLC 04/15/2025 18.70 K $33.00 K   -29.34% 0.03%
CREATIVE PLANNING 05/15/2025 14.30 K $25.03 K   1.33% 0.02%
CIBC WORLD MARKETS CORP 05/13/2025 14.01 K $24.52 K   100.00% 0.02%
PROSHARE ADVISORS LLC 05/08/2025 13.67 K $23.93 K   -23.13% 0.02%
05/09/2025 12.70 K $22.22 K   0.00% 0.02%

Regulus Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 80 institutional investors and hedge funds held shares of Regulus Therapeutics Inc.. The most heavily invested institutionals were:

FEDERATED HERMES, INC.: 15.82 M

NEA Management Company, LLC: 6.47 M

Octagon Capital Advisors LP: 4.64 M

BlackRock, Inc.: 4.17 M

VANGUARD GROUP INC: 3.95 M

Deep Track Capital, LP: 3.26 M

80.99% of Regulus Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 58.01 M shares in the last 24 months. This purchase volume represents approximately $472.22 M in transactions.